Galera Therapeutics Price on December 31, 2023
GRTXDelisted Stock | USD 2.58 0.19 6.86% |
If you're considering investing in Galera Pink Sheet, it is important to understand the factors that can impact its price. As of today, the current price of Galera Therapeutics stands at 2.58, as last reported on the 2nd of December, with the highest price reaching 2.77 and the lowest price hitting 2.54 during the day. We have found twenty-four technical indicators for Galera Therapeutics, which you can use to evaluate the volatility of the firm. Please check out Galera Therapeutics' Risk Adjusted Performance of 0.0045, market risk adjusted performance of (0.02), and Standard Deviation of 3.87 to validate if the risk estimate we provide is consistent with the expected return of 0.0%.
Galera Pink Sheet price history is provided at the adjusted basis, taking into account all of the recent filings.
Galera |
Sharpe Ratio = 0.0
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
GRTX |
Based on monthly moving average Galera Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Galera Therapeutics by adding Galera Therapeutics to a well-diversified portfolio.
Related Headline
Amylyx Pharmaceuticals Headline on 29th of December 2023
Exercise or conversion by Olinger Margaret of 25000 shares o... by Olinger Margaret
Filed transaction by Amylyx Pharmaceuticals In officer. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
Galera Therapeutics Valuation on December 31, 2023
It is possible to determine the worth of Galera Therapeutics on a given historical date. On December 31, 2023 Galera was worth 2.77 at the beginning of the trading date compared to the closed value of 2.58. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Galera Therapeutics pink sheet. Still, in general, we apply an absolute valuation method to find Galera Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Galera Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Galera Therapeutics' related companies.
Open | High | Low | Close | Volume | |
2.84 | 2.84 | 2.70 | 2.74 | 725,300 | |
07/24/2023 | 2.77 | 2.77 | 2.54 | 2.58 | 1,507,503 |
2.77 | 2.77 | 2.54 | 2.58 | 0.00 |
Backtest Galera Therapeutics | | | Galera Therapeutics History | | | Galera Therapeutics Valuation | Previous | Next |
Galera Therapeutics Trading Date Momentum on December 31, 2023
On December 02 2024 Galera Therapeutics was traded for 2.58 at the closing time. The top price for the day was 2.77 and the lowest listed price was 2.54 . There was no trading activity during the period 0.0. Lack of trading volume on December 2, 2024 did not cause price change. The overall trading delta against the current closing price is 7.36% . |
Galera Therapeutics Fundamentals Correlations and Trends
By evaluating Galera Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Galera Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Galera financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Galera Therapeutics Pink Sheet history
Galera Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Galera is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Galera Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Galera Therapeutics stock prices may prove useful in developing a viable investing in Galera Therapeutics
Galera Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer. The company was incorporated in 2012 and is headquartered in Malvern, Pennsylvania. Galera Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 30 people.
Galera Therapeutics Pink Sheet Technical Analysis
Galera Therapeutics technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
Price Boundaries
Galera Therapeutics Period Price Range
Low | December 2, 2024
| High |
0.00 | 0.00 |
Galera Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on PINK Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Galera Therapeutics December 2, 2024 Market Strength
Market strength indicators help investors to evaluate how Galera Therapeutics pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Galera Therapeutics shares will generate the highest return on investment. By undertsting and applying Galera Therapeutics pink sheet market strength indicators, traders can identify Galera Therapeutics entry and exit signals to maximize returns
Galera Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Galera Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Galera Pink Sheet historical price patterns, it is also worthwhile for investors to track various predictive indicators of Galera to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.0045 | |||
Jensen Alpha | (0.14) | |||
Total Risk Alpha | (0.67) | |||
Treynor Ratio | (0.03) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Other Consideration for investing in Galera Pink Sheet
If you are still planning to invest in Galera Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Galera Therapeutics' history and understand the potential risks before investing.
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |